What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply.
作者信息
Calais Jeremie, Ceci Francesco, Eiber Matthias, Hope Thomas A, Hofman Michael S, Rischpler Christoph, Bach-Gansmo Tore, Fendler Wolfgang P, Czernin Johannes
机构信息
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Institute of Urologic Oncology, University of California Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, USA.
Ahmanson Translational Theranostics Division, Department of Medical and Molecular Pharmacology, University of California Los Angeles, CA 900095-7370, USA; Nuclear Medicine, Department of Medical Sciences, University of Turin, Italy.
出版信息
Lancet Oncol. 2019 Nov;20(11):e609-e610. doi: 10.1016/S1470-2045(19)30654-0.
Zotero 插件